Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616369 · ClinicalTrials.gov registry record
Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 255
- Enrollment target
NCT00616369: Completed study, sponsored by University of Alabama at Birmingham.
NCT00616369 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00616369 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
This study is designed to investigate whether an association exists between certain genes/protein levels and the development of various cardiopulmonary diseases. It is hoped that this project will provide valuable insight into the understanding of these diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-01 |
What the finished NCT00616369 record still lists
NCT00616369 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00616369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00616369 about?
NCT00616369 is a clinical study titled "Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)". This study is designed to investigate whether an association exists between certain genes/protein levels and the development of various cardiopulmonary diseases. It is hoped that this project will provide valuable insight into the understanding of these diseases.
What is the current status of trial NCT00616369?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2008-01. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT00616369?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia